Results 161 to 170 of about 20,409 (197)

Perspectives of Pegylated Interferon Use in Dermatological Oncology

2002
The potent immunomodulatory, antiproliferative and antiviral properties of interferons (IFNs), together with their availability in large amounts thanks to the recombinant DNA technique, have resulted in their widespread clinical use in a variety of viral and nonviral proliferative disorders.
openaire   +2 more sources

Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C

European Journal of Gastroenterology & Hepatology, 2014
Andrea, Messori, Valeria, Fadda, Dario, Maratea, Sabrina, Trippoli, Claudio, Marinai   +4 more
openaire   +2 more sources

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Lancet, The, 2005
Harry La Janssen, Monika van Zonneveld, Ulus S Akarca   +2 more
exaly  

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Lancet, The, 2008
Alexander Mm Eggermont, Mario Santinami, Alessandro Testori   +2 more
exaly  

Pegylated Interferons

2006
openaire   +1 more source

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications

Advanced Drug Delivery Reviews, 2002
Daniel F Wyss
exaly  

Allergic sensitization to pegylated interferon‐α results in drug eruptions

Allergy: European Journal of Allergy and Clinical Immunology, 2015
Stephan Meller, A Erhardt, B Homey
exaly  

Pegylated Interferons

2008
openaire   +1 more source

Efficacy and Safety of Pegylated Interferon Alfa-2b and Ribavirin Combination Therapy Versus Pegylated Interferon Monotherapy in Hemodialysis Patients: A Comparison of 2 Sequentially Treated Cohorts

American Journal of Kidney Diseases, 2013
Yu-Shu Chien, Ming-Chao Tsai, Chien-Heng Shen   +2 more
exaly  

Pegylated Interferons

2011
openaire   +1 more source